Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT02361086. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
ClinicalTrials.gov study NCT02282644. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT00326586. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Panc
ClinicalTrials.gov study NCT05922930. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment
ClinicalTrials.gov study NCT03672240. IPD Sharing: NO. Countries: 1. Publications: 0.
Lapatinib Resistance in Patients With Breast Cancer
ClinicalTrials.gov study NCT00898573. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) Progressing
ClinicalTrials.gov study NCT06460454. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT07298239. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT06800313. IPD Sharing: NO. Countries: 2. Publications: 0.
XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT05005728. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT06842498. IPD Sharing: Not stated. Countries: 1. Publications: 0.
FPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT06909825. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
ClinicalTrials.gov study NCT07103018. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer
ClinicalTrials.gov study NCT00897702. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exploratory Study on the Safety and Efficacy of Disitamab Vedotin in Combination with Anlotinib Hydrochloride for the Treatment of HER-2-expressing Recurrent Platinum-resistant Ovarian Cancer.
ClinicalTrials.gov study NCT06660511. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT07389187. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）
ClinicalTrials.gov study NCT07104643. IPD Sharing: NO. Countries: 1. Publications: 0.
Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
ClinicalTrials.gov study NCT01606982. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT05145218. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer
ClinicalTrials.gov study NCT07117877. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.